Literature DB >> 10779445

Importance of L-selectin-dependent leukocyte-leukocyte interactions in human whole blood.

D J Mitchell1, P Li, P H Reinhardt, P Kubes.   

Abstract

The objective of this study was to investigate whether leukocytes could be recruited by rolling leukocytes in a human whole blood model system. In all experiments, either neutrophils, whole blood, or diluted blood was perfused over immobilized E-selectin. With isolated neutrophils (2 x 10(5)/mL), the free-flowing neutrophils were captured by attached neutrophils to form secondary interactions that resulted in lines of rolling leukocytes. These secondary tethers accounted for 50% to 60% of all interactions and were eliminated by an L-selectin antibody, which also eliminated the lines of rolling leukocytes. Perfusion of whole blood or diluted blood revealed no lines of rolling leukocytes. The addition of red blood cells to isolated neutrophils either in a 1000:1 or a 10:1 ratio also inhibited lines of rolling leukocytes. Leukocytes were fluorescently labeled with rhodamine-6G so that leukocyte-leukocyte interactions could be studied in whole blood. A small number of secondary tethers (less than 20%) occurred and could be reduced by more than 80% with an L-selectin antibody. However, the overall impact on leukocyte recruitment was negligible. Similar experiments were performed using murine whole blood or isolated murine leukocytes. In the absence of red blood cells, murine leukocytes also formed lines of rolling leukocytes on E-selectin, and secondary tethers accounted for 50% of total interactions. However, when murine blood (diluted 1:5 with buffer) was perfused over E-selectin, secondary tethers accounted for only 13% of total interactions. These interactions were completely absent when blood was used from L-selectin-deficient mice. These data demonstrate for the first time that the importance of L-selectin-dependent leukocyte-leukocyte interactions is greatly reduced in whole blood and does not enhance overall recruitment of leukocytes in this physiologic milieu. (Blood. 2000;95:2954-2959)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779445

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Multiparticle adhesive dynamics: hydrodynamic recruitment of rolling leukocytes.

Authors:  M R King; D A Hammer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Red blood cells augment leukocyte rolling in a virtual blood vessel.

Authors:  Cristiano Migliorini; YueHong Qian; Hudong Chen; Edward B Brown; Rakesh K Jain; Lance L Munn
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

3.  [Effects of reduced shear stress on inflammatory reactions in vitro. Effects of pathological flow conditions on leukocyte-endothelial interactions and monocyte tissue factor expression in human cell cultures].

Authors:  B Nohé; T Johannes; V Schmidt; T H Schroeder; R T Kiefer; K Unertl; H J Dieterich
Journal:  Anaesthesist       Date:  2005-08       Impact factor: 1.041

4.  Forces on a wall-bound leukocyte in a small vessel due to red cells in the blood stream.

Authors:  Amir H G Isfahani; Jonathan B Freund
Journal:  Biophys J       Date:  2012-10-02       Impact factor: 4.033

5.  Estimating the efficiency of cell capture and arrest in flow chambers: study of neutrophil binding via E-selectin and ICAM-1.

Authors:  Yi Zhang; Sriram Neelamegham
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

6.  Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo.

Authors:  E E Eriksson; X Xie; J Werr; P Thoren; L Lindbom
Journal:  J Exp Med       Date:  2001-07-16       Impact factor: 14.307

7.  Real-time high resolution 3D imaging of the lyme disease spirochete adhering to and escaping from the vasculature of a living host.

Authors:  Tara J Moriarty; M Ursula Norman; Pina Colarusso; Troy Bankhead; Paul Kubes; George Chaconas
Journal:  PLoS Pathog       Date:  2008-06-20       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.